Suppr超能文献

关于脂质体作为药物纳米载体我们需要了解的内容:最新综述

What We Need to Know about Liposomes as Drug Nanocarriers: An Updated Review.

作者信息

Abbasi Hanieh, Kouchak Maryam, Mirveis Zohreh, Hajipour Fatemeh, Khodarahmi Mohsen, Rahbar Nadereh, Handali Somayeh

机构信息

Department of Medicinal Chemistry, School of Pharmacy, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.

Nanotechnology Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.

出版信息

Adv Pharm Bull. 2023 Jan;13(1):7-23. doi: 10.34172/apb.2023.009. Epub 2022 Apr 4.

Abstract

Liposomes have been attracted considerable attention as phospholipid spherical vesicles, over the past 40 years. These lipid vesicles are valued in biomedical application due to their ability to carry both hydrophobic and hydrophilic agents, high biocompatibility and biodegradability. Various methods have been used for the synthesis of liposomes, so far and numerous modifications have been performed to introduce liposomes with different characteristics like surface charge, size, number of their layers, and length of circulation in biological fluids. This article provides an overview of the significant advances in synthesis of liposomes via active or passive drug loading methods, as well as describes some strategies developed to fabricate their targeted formulations to overcome limitations of the "first-generation" liposomes.

摘要

在过去40年里,脂质体作为磷脂球形囊泡已引起了相当大的关注。这些脂质囊泡在生物医学应用中备受重视,因为它们能够携带疏水和亲水药物、具有高生物相容性和可生物降解性。到目前为止,已经使用了各种方法来合成脂质体,并进行了大量修饰以引入具有不同特性的脂质体,如表面电荷、大小、层数以及在生物流体中的循环时间。本文概述了通过主动或被动载药方法合成脂质体的重大进展,并描述了为制备其靶向制剂以克服“第一代”脂质体局限性而开发的一些策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/238a/9871273/d60f7e193ab5/apb-13-7-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验